General Insurance Corporation reports 20% fall in Q4 net profit
General Insurance Corporation of India has reported results for fourth quarter and year ended March 31, 2019. The company has reported a fall of…
Author: admin
Xchanging Solutions receives approval for voluntarily liquidation of wholly owned subsidiary
Xchanging Solutions has received approval for voluntarily liquidation of Xchanging Solutions (Europe) (XSEL), a Wholly Owned Subsidiary of the company. XSEL does not undertake…
Gokak Textiles to raise Rs 30 crore on private placement basis
Gokak Textiles has received approval for issuance of Non-cumulative, Non-convertible, Non-participating, Redeemable Preference Shares of Rs 10 each aggregating to Rs 30 crore in one…
Universal Auto Foundry establishes project at Rajasthan
Universal Auto Foundry has almost established a Project at B-51, SKS Industrial Area, Reengus, District Sikar, Rajasthan (UNIT II) and in relation to the same…
BOC Aviation delivers three Boeing aircraft to SpiceJet
BOC Aviation has delivered three Boeing B737-800 NG aircraft to SpiceJet. The three aircraft are powered by CFM56 engines. SpiceJet is among the first…
NCLT approves amalgamation of Zydus Wellness’ two subsidiaries
National Company Law Tribunal (NCLT), Bench at Ahmedabad has given an approval to Zydus Wellness for the Scheme of Amalgamation (Scheme) between two subsidiaries, Heinz…
Bharti Airtel’s DTH arm launches six new recharge plans: Report
Airtel Digital TV, the DTH arm of Bharti Airtel, has reportedly launched six new recharge plans for its DTH users. Users can choose between HD…
Reliance Capital and Nippon to end their joint venture in Mutual Funds
New Delhi, May 23 (Udaipur Kiran): As per the advice by JM Financial Limited, Reliance Capital is selling its stake in Reliance Nippon Life Asset…
Quess Corp reports marginal fall in Q4 consolidated net profit
Quess Corp has reported results for fourth quarter and year ended March 31, 2019. The company has reported a rise of 47.66% in its net…
Suven Life Sciences completes Phase 2 study of SUVN-502 for moderate Alzheimer’s disease
Suven Life Sciences has completed last patient last visit (LPLV) for its Phase 2 POC study of SUVN-502 for moderate Alzheimer’s disease. The company expects…